Crystalvue Medical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	905.73	868.03	823.96	795.46	721.61	504.37
Revenue Growth (YoY)	8.65%	5.35%	3.58%	10.23%	43.07%	-23.71%
Cost of Revenue	588.29	568.89	557.22	533.71	510.22	338.98
Gross Profit	317.45	299.14	266.75	261.74	211.39	165.39
Selling, General & Admin	106.36	108.48	104.4	89.97	73.73	66.45
Research & Development	41.39	45.66	44.67	46.97	49.2	41.28
Operating Expenses	147.75	154.14	149.07	136.94	122.93	107.73
Operating Income	169.7	145.01	117.68	124.8	88.47	57.66
Interest Expense	-0.5	-0.63	-0.82	-1	-1.17	-1.34
Interest & Investment Income	2.48	2.14	1.47	0.47	1.06	1.89
Earnings From Equity Investments	-	-	-	-	-	-0.02
Currency Exchange Gain (Loss)	-4.09	6.33	1.19	10.68	-2.11	-4.55
Other Non Operating Income (Expenses)	0.62	6.53	0.22	7.48	8.97	9.33
EBT Excluding Unusual Items	168.2	159.38	119.74	142.44	95.22	62.97
Gain (Loss) on Sale of Assets	0.28	-	-	-	13.95	-
Pretax Income	168.48	159.38	119.74	142.44	109.17	62.97
Income Tax Expense	29.21	32.23	16.34	27.41	31.93	6.35
Net Income	139.27	127.15	103.4	115.03	77.24	56.62
Net Income to Common	139.27	127.15	103.4	115.03	77.24	56.62
Net Income Growth	20.30%	22.98%	-10.11%	48.93%	36.42%	-37.84%
Shares Outstanding (Basic)	25	25	25	25	25	25
Shares Outstanding (Diluted)	26	26	25	26	25	26
Shares Change (YoY)	0.84%	1.64%	-0.91%	0.53%	-0.99%	13.00%
EPS (Basic)	5.50	5.02	4.13	4.59	3.08	2.23
EPS (Diluted)	5.41	4.95	4.09	4.51	3.05	2.21
EPS Growth	19.54%	21.03%	-9.31%	47.98%	37.93%	-45.02%
Free Cash Flow	-101.53	22.62	149.64	44.24	-287.91	53.77
Free Cash Flow Per Share	-3.94	0.88	5.92	1.73	-11.35	2.10
Dividend Per Share	2.250	2.250	2.070	2.286	1.848	1.333
Dividend Growth	8.70%	8.70%	-9.44%	23.71%	38.57%	-45.10%
Gross Margin	35.05%	34.46%	32.37%	32.91%	29.29%	32.79%
Operating Margin	18.74%	16.71%	14.28%	15.69%	12.26%	11.43%
Profit Margin	15.38%	14.65%	12.55%	14.46%	10.70%	11.22%
Free Cash Flow Margin	-11.21%	2.61%	18.16%	5.56%	-39.90%	10.66%
EBITDA	181.3	165.75	139.51	143.92	122.55	76.31
EBITDA Margin	20.02%	19.10%	16.93%	18.09%	16.98%	15.13%
D&A For EBITDA	11.6	20.75	21.83	19.11	34.09	18.66
EBIT	169.7	145.01	117.68	124.8	88.47	57.66
EBIT Margin	18.74%	16.71%	14.28%	15.69%	12.26%	11.43%
Effective Tax Rate	17.34%	20.22%	13.65%	19.25%	29.25%	10.08%
Advertising Expenses	-	-	-	-	26.55	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.